Meningitis meningococcal – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Tue, 02 Jun 2026 04:14:55 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Meningitis meningococcal – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on the Safety and Immune Response of MenABCWY Vaccine and Drug Combination in Healthy Infants with Meningococcal Infections https://clinicaltrials.eu/trial/study-on-the-safety-and-immune-response-of-menabcwy-vaccine-and-drug-combination-in-healthy-infants-with-meningococcal-infections/ Wed, 29 Apr 2026 15:05:43 +0000 https://clinicaltrials.eu/trial/study-on-the-safety-and-immune-response-of-menabcwy-vaccine-and-drug-combination-in-healthy-infants-with-meningococcal-infections/ This clinical trial is focused on studying a disease called meningococcal infection, which is caused by bacteria that can lead to serious illnesses like meningitis. The study is testing a new vaccine called MenABCWY, which is designed to protect against several groups of the bacteria that cause these infections. The trial will also involve other vaccines, including MenB and MenACWY-TT, to compare their effectiveness and safety. The purpose of the study is to evaluate how safe these vaccines are and how well they work in producing an immune response in healthy infants.

Participants in the study will receive the vaccines as injections. The study will monitor the infants over a period of time to observe any reactions to the vaccines and to measure the immune response. This will help determine how well the vaccines protect against the different groups of the bacteria. The study will also include a comparison with a placebo to ensure the results are accurate.

The trial will take place over several months, with multiple visits for vaccinations and follow-up checks. The researchers will collect data on any side effects and the overall health of the participants. This information will be used to assess the safety and effectiveness of the vaccines in preventing meningococcal infection in infants. The study aims to provide valuable insights into the best ways to protect against this serious disease.

]]> Study on the Safety and Immune Response of MenABCWY Vaccine in Healthy Adolescents Aged 11-14 with Meningococcal Meningitis https://clinicaltrials.eu/trial/study-on-the-safety-and-immune-response-of-menabcwy-vaccine-in-healthy-adolescents-aged-11-14-with-meningococcal-meningitis/ Wed, 29 Apr 2026 15:05:26 +0000 https://clinicaltrials.eu/trial/study-on-the-safety-and-immune-response-of-menabcwy-vaccine-in-healthy-adolescents-aged-11-14-with-meningococcal-meningitis/ This clinical trial is focused on studying a disease called meningococcal meningitis, which is a serious infection that affects the protective membranes covering the brain and spinal cord. The study is testing a vaccine known as MenABCWY, which is designed to protect against several groups of bacteria that can cause this disease. The vaccine is given as an injection and is being tested to see how well it works and how safe it is for use in healthy adolescents aged 11 to 14 years.

The purpose of the study is to understand the immune response, which is how the body defends itself against infections, to two doses of the MenABCWY vaccine. The study will look at different schedules for giving the vaccine, specifically at 0 and 24 months, and at 0 and 48 months. Participants will receive the vaccine through an injection into the muscle, and the study will monitor their health and any reactions to the vaccine over time.

Throughout the study, participants will be observed for any side effects or reactions to the vaccine. The study aims to ensure the vaccine is safe and to measure how well it helps the body build protection against the bacteria that cause meningococcal meningitis. This research is important for developing effective vaccines to prevent this serious disease in young people.

]]>